Phenotypic and Molecular Genetic Resistance of Mycobacterium tuberculosis to Fluoroquinolones: A Literature Review
Open Access
- 16 July 2026
- journal article
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (3) , 107-117
Abstract
Fluoroquinolones are essential drugs for the treatment of drug-resistant tuberculosis; however, the rise in resistance to these agents significantly reduces treatment efficacy. This review summarizes current data on the molecular genetic and phenotypic mechanisms of Mycobacterium tuberculosis resistance to fluoroquinolones. Particular attention is focused on mutations in the gyrA and gyrB genes encoding DNA gyrase, the primary target of fluoroquinolones. Mutations within the QRDR of gyrA are the major determinants of resistance and are associated with an increase in the minimum inhibitory concentrations of fluoroquinolones. This review examines the role of alternative resistance mechanisms, including efflux pump systems and glpK -associated adaptations, as well as the importance of the WHO Catalogue of Mutations for variant interpretation. The integration of phenotypic and molecular diagnostic approaches is essential for the effective detection and control of drug-resistant tuberculosis.Keywords
This publication has 44 references indexed in Scilit:
- The Global Intensive Care UnitCritical Care Clinics, 2026
- Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitisThe Brazilian Journal of Infectious Diseases, 2024
- Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug toleranceProceedings of the National Academy of Sciences, 2019
- The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from IranBrazilian Journal of Microbiology, 2016
- Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective studyThe Lancet Respiratory Medicine, 2016
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyThe Lancet Infectious Diseases, 2015
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An UpdateDrugs, 2014
- Mechanism of Quinolone Action and ResistanceBiochemistry, 2014
- Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyThe Lancet, 2012
- Fluoroquinolones, tuberculosis, and resistanceThe Lancet Infectious Diseases, 2003